Previous Close | 1.8400 |
Open | 1.8300 |
Bid | 1.8000 x 4000 |
Ask | 1.8000 x 1100 |
Day's Range | 1.7000 - 1.8500 |
52 Week Range | 0.2100 - 1.9000 |
Volume | |
Avg. Volume | 4,394,695 |
Market Cap | 1.033B |
Beta (5Y Monthly) | 1.43 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Impressive quarterly performance with significant revenue growth and strategic advancements in radiopharmaceuticals.
Significant R&D Investments Lead to Increased Losses Despite Revenue Gains from Grants
PTC Therapeutics (PTCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.